Keros Therapeutics, Inc. (KROS)
NASDAQ: KROS · Real-Time Price · USD
11.34
+0.35 (3.18%)
Mar 25, 2026, 4:00 PM EDT - Market closed

Keros Therapeutics Stock Forecast

Stock Price Forecast

The 8 analysts that cover Keros Therapeutics stock have a consensus rating of "Buy" and an average price target of $22.25, which forecasts a 96.21% increase in the stock price over the next year. The lowest target is $16 and the highest is $27.

Price Target: $22.25 (+96.21%)
Analyst Consensus: Buy
TargetLowAverageMedianHigh
Price$16$22.25$25$27
Change+41.09%+96.21%+120.46%+138.10%

Analyst Ratings

The average analyst rating for Keros Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

RatingOct '25Nov '25Dec '25Jan '26Feb '26Mar '26
Strong Buy333333
Buy355553
Hold877772
Sell000000
Strong Sell000000
Total14151515158

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Wells Fargo
Wells Fargo
Buy
Maintains
$23$20
BuyMaintains$23$20+76.37%Mar 5, 2026
B of A Securities
B of A Securities
Hold
Maintains
$18$19
HoldMaintains$18$19+67.55%Nov 28, 2025
Oppenheimer
Oppenheimer
Buy
Reiterates
$23$27
BuyReiterates$23$27+138.10%Nov 12, 2025
Wells Fargo
Wells Fargo
Buy
Maintains
$26$23
BuyMaintains$26$23+102.82%Nov 11, 2025
Wedbush
Wedbush
Hold
Maintains
$15$16
HoldMaintains$15$16+41.09%Nov 6, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
340.00K
from 244.06M
Decreased by -99.86%
Revenue Next Year
2.81M
from 340.00K
Increased by 727.07%
EPS This Year
-3.62
from 2.30
EPS Next Year
-4.02
from -3.62
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026Dec 31, 2027
Revenue
20.10M-151.00K3.55M244.06M340.00K2.81M
Revenue Growth
---2,250.99%6,774.96%-99.86%727.07%
EPS
-2.52-4.15-5.20-5.002.30-3.62-4.02
EPS Growth
-------
Forward PE
-------
No. Analysts
-----1110
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20262027202820292030
High2.1M15.8M
Avg339,9972.8M
Lown/an/a

Revenue Growth

Revenue Growth20262027202820292030
High
-99.1%
4,532.4%
Avg
-99.9%
727.1%
Low--

EPS Forecast

EPS20262027202820292030
High-1.34-2.86
Avg-3.62-4.02
Low-4.82-5.60

EPS Growth

EPS Growth20262027202820292030
High--
Avg--
Low--
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.